Promising drugs that could save lives face a “Valley of Death” when moving from basic research to clinical study and into the marketplace. That was the message and the focus of a national town hall held in Kansas City on Tuesday.
The New Role of Academia in Drug Discovery and Development Town Hall brought together an elite group of senior government officials and leading experts representing industry, academia, venture capital, technology centers and venture philanthropy. Speakers included Kathleen Sebelius, secretary of Health and Human Services; Francis Collins, director of the National Institutes of Health; Margaret Hamburg, commissioner for the Food and Drug Administration; and former House Majority Leader Richard Gephardt, now chairman of the Council for American Medical Innovation.
Sebelius told attendees that the future of the country and the region is tied to the success of bioscience. “We are at a pivotal moment in bioscience research in America,” Sebelius said.
She lauded the dedication to bioscience “seen here in the Heartland,” and said we can’t have a healthier country without a focus on long-term investment and a national commitment to science.
To read the full, original article click on this link: Small Business Has Role in Bridging 'Valley of Death'
Author: Small Business
